STOCK TITAN

Relay Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Relay Therapeutics, Inc. (RLAY) will participate in three fireside chats to discuss its precision medicine approach and drug discovery process using computational and experimental technologies. The chats will be webcast live and accessible through the company's website.
Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in three upcoming fireside chats:

  • Stifel 2024 Virtual Targeted Oncology Forum on Wednesday, April 17, 2024 at 1:00 p.m. ET
  • The Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024 at 11:30 a.m. ET
  • BofA Securities Health Care Conference 2024 on Tuesday, May 14, 2024 at 1:40 p.m. PT

The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the event.

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of complementary techniques and technologies, Relay Therapeutics aims to push the boundaries of what’s possible in drug discovery. Its Dynamo™ platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com or follow us on Twitter.

Contact:
Megan Goulart
617-545-5526
mgoulart@relaytx.com

Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com


FAQ

When will Relay Therapeutics participate in the Stifel 2024 Virtual Targeted Oncology Forum?

Relay Therapeutics will participate in the Stifel 2024 Virtual Targeted Oncology Forum on Wednesday, April 17, 2024, at 1:00 p.m. ET.

What is the date and time of Relay Therapeutics' participation in the Citizens JMP Life Sciences Conference?

Relay Therapeutics will participate in the Citizens JMP Life Sciences Conference on Tuesday, May 14, 2024, at 11:30 a.m. ET.

When is Relay Therapeutics scheduled to participate in the BofA Securities Health Care Conference 2024?

Relay Therapeutics is scheduled to participate in the BofA Securities Health Care Conference 2024 on Tuesday, May 14, 2024, at 1:40 p.m. PT.

How can the fireside chats be accessed?

The fireside chats can be accessed live through Relay Therapeutics' website under Events in the News & Events section via the provided link: https://ir.relaytx.com/news-events/events-presentations.

Will there be a replay available for the webcasts?

Yes, an archived replay of the webcasts will be available for up to 30 days following the events.

Relay Therapeutics, Inc.

NASDAQ:RLAY

RLAY Rankings

RLAY Latest News

RLAY Stock Data

931.64M
93.01M
3.49%
99.09%
8.52%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
CAMBRIDGE

About RLAY

relay therapeutics is building the world’s first dedicated drug discovery platform centered on protein motion to discover and develop new medicines that will make a transformative difference for patients. by placing protein motion at the heart of drug discovery, relay is pursuing what it believes will be a fundamental paradigm shift within the pharmaceutical industry, ushering in a new generation of drugs with the potential to improve and extend the lives of millions of patients. headquartered in cambridge, mass., relay therapeutics is a private company launched in 2016. to date, relay therapeutics has raised $120m in financing from third rock ventures, bvf partners, gv (formerly google ventures), an affiliate of d.e. shaw research, casdin capital, ecor1 capital, section 32 and alexandria venture investments. our world-class team is equal parts bright and bold, with a shared passion for working in intellectually stimulating environments. if you're creative, collaborative and passionate